Chemomab Therapeutics Ltd
F:2QV0
Chemomab Therapeutics Ltd
F:2QV0
Price:
2.94
EUR
Market Cap:
€41.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Chemomab Therapeutics Ltd
F:2QV0
|
IL |
|
H
|
H & M Hennes & Mauritz AB
XMUN:HMSB
|
SE |
|
V
|
Verkkokauppa.com Oyj
F:15V
|
FI |
|
D
|
Defama Deutsche Fachmarkt AG
XMUN:DEF
|
DE |
|
Relo Group Inc
F:665
|
JP |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
Relo Group Inc
OTC:RELOF
|
JP |
|
V
|
VAALCO Energy Inc
F:VAW
|
US |
|
Raksul Inc
F:49R
|
JP |
Wall St Price Targets
2QV0 Price Targets Summary
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
Wall Street analysts forecast 2QV0 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 2QV0 is 24.58 EUR with a low forecast of 8.11 EUR and a high forecast of 42.17 EUR.
Lowest Forecast
Price Target
8.11
EUR
176% Upside
Average Forecast
Price Target
24.58
EUR
736% Upside
Highest Forecast
Price Target
42.17
EUR
1 334% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2QV0's stock price target?
Price Target
24.58
EUR
24.58
EUR
According to Wall Street analysts, the average 1-year price target for 2QV0 is 24.58 EUR with a low forecast of 8.11 EUR and a high forecast of 42.17 EUR.
